Results
|
1.
|
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A. [electronic resource] by
- Rutstein, Richard M
- Samson, Pearl
- Fenton, Terry
- Fletcher, Courtney V
- Kiser, Jennifer J
- Mofenson, Lynne M
- Smith, Elizabeth
- Graham, Bobbie
- Mathew, Marina
- Aldrovani, Grace
Producer: 20151113
In:
The Pediatric infectious disease journal vol. 34
Availability: No items available.
|
|
2.
|
Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment. [electronic resource] by
- Higa, Nikki
- Pelz, Amy
- Birch, Donald
- Beck, Ingrid A
- Sils, Tatiana
- Samson, Pearl
- Bwakura-Dangarembizi, Mutsawashe
- Bolton-Moore, Carolyn
- Capparelli, Edmund
- Chadwick, Ellen
- Frenkel, Lisa M
Producer: 20201204
In:
Journal of the Pediatric Infectious Diseases Society vol. 9
Availability: No items available.
|
|
3.
|
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. [electronic resource] by
- Kiser, Jennifer J
- Rutstein, Richard M
- Samson, Pearl
- Graham, Bobbie
- Aldrovandi, Grace
- Mofenson, Lynne M
- Smith, Elizabeth
- Schnittman, Steven
- Fenton, Terry
- Brundage, Richard C
- Fletcher, Courtney V
Producer: 20110914
In:
AIDS (London, England) vol. 25
Availability: No items available.
|
|
4.
|
Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children. [electronic resource] by
- Fletcher, Courtney V
- DeVille, Jaime G
- Samson, Pearl M
- Moye, John H
- Church, Joseph A
- Spiegel, Hans M L
- Palumbo, Paul
- Fenton, Terence
- Smith, M Elizabeth
- Graham, Bobbie
- Kraimer, Joyce M
- Shearer, William T
Producer: 20070412
In:
The Journal of allergy and clinical immunology vol. 119
Availability: No items available.
|
|
5.
|
Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years. [electronic resource] by
- Bwakura Dangarembizi, Mutsa
- Samson, Pearl
- Capparelli, Edmund V
- Moore, Carolyn Bolton
- Jean-Philippe, Patrick
- Spector, Stephen A
- Chakhtoura, Nahida
- Benns, Alex
- Zimmer, Bonnie
- Purdue, Lynette
- Jackson, Chivon
- Wallis, Carole
- Libous, Jennifer L
- Chadwick, Ellen G
Producer: 20200224
In:
Journal of acquired immune deficiency syndromes (1999) vol. 81
Availability: No items available.
|
|
6.
|
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. [electronic resource] by
- Meyers, Tammy
- Samson, Pearl
- Acosta, Edward P
- Moye, Jack
- Townley, Ellen
- Bradford, Sarah
- Marillo, Linda
- Denson, Kayla
- Hovind, Laura
- Sise, Thucuma
- Teppler, Hedy
- Mathiba, Sisinyana Ruth
- Masenya, Masebole
- Hesseling, Anneke
- Cotton, Mark F
- Krogstad, Paul
Producer: 20200930
In:
AIDS (London, England) vol. 33
Availability: No items available.
|
|
7.
|
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection. [electronic resource] by
- Bolton Moore, Carolyn
- Capparelli, Edmund V
- Samson, Pearl
- Bwakura-Dangarembizi, Mutsa
- Jean-Philippe, Patrick
- Worrell, Carol
- Heckman, Barbara
- Purdue, Lynette
- Spector, Stephen A
- Benns, Alex
- Borkowsky, William
- Loftis, Amy
- Hawkins, Elizabeth
- Wallis, Carole
- Chadwick, Ellen G
Producer: 20180109
In:
AIDS (London, England) vol. 31
Availability: No items available.
|
|
8.
|
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). [electronic resource] by
- Shearer, William T
- DeVille, Jaime G
- Samson, Pearl M
- Moye, John H
- Fletcher, Courtney V
- Church, Joseph A
- Spiegel, Hans M L
- Palumbo, Paul
- Fenton, Terence
- Smith, M Elizabeth
- Graham, Bobbie
- Kraimer, Joyce M
- Olson, William C
Producer: 20060908
In:
The Journal of allergy and clinical immunology vol. 118
Availability: No items available.
|
|
9.
|
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. [electronic resource] by
- Nachman, Sharon
- Ahmed, Amina
- Amanullah, Farhana
- Becerra, Mercedes C
- Botgros, Radu
- Brigden, Grania
- Browning, Renee
- Gardiner, Elizabeth
- Hafner, Richard
- Hesseling, Anneke
- How, Cleotilde
- Jean-Philippe, Patrick
- Lessem, Erica
- Makhene, Mamodikoe
- Mbelle, Nontombi
- Marais, Ben
- McIlleron, Helen
- McNeeley, David F
- Mendel, Carl
- Murray, Stephen
- Navarro, Eileen
- Anyalechi, E Gloria
- Porcalla, Ariel R
- Powell, Clydette
- Powell, Mair
- Rigaud, Mona
- Rouzier, Vanessa
- Samson, Pearl
- Schaaf, H Simon
- Shah, Seema
- Starke, Jeff
- Swaminathan, Soumya
- Wobudeya, Eric
- Worrell, Carol
Producer: 20150803
In:
The Lancet. Infectious diseases vol. 15
Availability: No items available.
|